Skip to main content
TrialFinder
ResourcesAbout
ⓘNot medical advice.▾

This site is for general information only and is not medical advice, diagnosis, or treatment. Always talk to a qualified clinician before medical decisions. TrialFinder is not affiliated with trial sponsors or healthcare providers.

Privacy policyTerms of useAccessibilityFAQFeedback
Support the project (opens in a new tab)

We use functional cookies to improve your experience. See our Privacy policy.

Trial data comes from ClinicalTrials.gov (US) and is shown for information only.

In memory of Dov Korn ❤️

Before You Join a Clinical Trial: Screening, Informed Consent, and Red Flags | TrialFinder
HomeResourcesBefore You Join a Clinical Trial: Screening, Informed Consent, and Red Flags

Back to Resources

Published · September 12, 2026

Before You Join a Clinical Trial: Screening, Informed Consent, and Red Flags

You found a trial that looks right. Maybe your doctor suggested it, maybe you found it yourself. Either way, the moment between "this could help" and the first dose or session is not a formality. It is a structured process designed to protect you, and it works best when you understand it.

This guide covers that process for any condition: what screening involves, what the consent form must tell you, the questions worth asking, the fears almost everyone has, and the red flags that should make you walk away.

What happens before you join: screening

Finding a promising trial is only the beginning. Next comes screening, a series of questions and tests that confirm you meet the study's eligibility criteria.

Before you reach that official step, TrialFinder has a quick eligibility check on each trial page. It is a first pass, not a substitute for the research team's screening, but it can help you see whether the basic criteria look like a fit.

The research team may ask about your diagnosis, symptoms, medications, previous treatments, other medical conditions, hospitalizations, and family medical history. Depending on the study, screening may also include blood tests, imaging, an ECG, a physical exam, or a detailed interview with a specialist.

Some of these questions can feel personal. You are allowed to ask why the information is needed, who will see it, and how it will be stored.

Screening protects you as much as it protects the study. A "no" at this stage usually means the treatment was not designed, or has not been proven safe, for someone with your specific profile. It is not a judgment about how sick you are or how much you deserve help.

The informed consent form: what it must explain

Before you join, you will receive an informed consent form. This is not a signature for the sake of bureaucracy. It is the document that tells you what you are agreeing to, and it should explain, in plain language:

  • What the study is testing, and why
  • What will happen at each visit
  • Which parts are experimental and which are standard care
  • Known and possible risks and side effects
  • Whether a placebo or comparison treatment is used, and what that means in practice
  • What happens if your condition gets worse during the study
  • What costs are covered and what is not
  • Whether travel or time is reimbursed
  • How your medical information will be used and protected
  • Who to contact with questions or urgent concerns
  • Your right to leave the study at any time, for any reason, without losing your regular care

Consent is not a test, and it is not a promise to finish the study. Take the form home if the study allows it. Read it with someone you trust. Ask the team to explain anything that does not make sense. A good research team will welcome the questions.

One more layer of protection worth knowing about: every legitimate trial is reviewed and approved by an independent ethics committee before it begins - an Institutional Review Board (IRB) in the US and many other countries, or a Helsinki Committee in Israel. This committee is not part of the research team. Its job is to check that the protocol is safe and fair, and that the consent form tells you the truth. If a study cannot tell you which ethics committee approved it, that alone is a reason to walk away.

The most important questions to ask

You do not need a medical degree to interview a research team. Start with these:

What treatment might I actually receive? Ask about every study group, including placebo, standard care, or a comparison treatment, and how participants are assigned to groups.

Will my current treatment change? If the study asks you to stop, pause, or adjust a medication or treatment, ask who supervises the change, how it happens, and what the plan is if you feel worse.

What are the known risks? Ask about common side effects, rare serious risks, and any risk specific to the treatment being studied.

What happens if I get worse? There should be a clear plan. Ask whether support is available after hours, who decides whether you should stop, and how the team coordinates with your regular doctor.

Does the research team replace my regular doctor? In most studies, it does not. Ask how the two will share information.

How much time will this take? Ask about visit length and frequency, travel, remote check-ins, diaries or questionnaires, follow-up after treatment ends, and whether someone needs to come with you.

What will I have to pay? The study treatment and research-only tests are often covered by the sponsor, but routine medical care, transport, or time off work may not be. Ask what is paid for and what is not.

What happens when the study ends? Can you continue the treatment if it helped? Will the team help you transition back to ordinary care? Will they tell you which group you were in, and share the results?

Who can see my information? Ask how your medical notes, test results, samples, and any app or device data will be protected, and whether de-identified data may be used in future research.

Write the answers down. The right trial should still make sense after the excitement of finding it wears off.

Common fears, answered plainly

"Am I being used as a guinea pig?"

No one can promise that an experimental treatment will work. That uncertainty is the reason the trial exists. But a legitimate study must explain the risks, follow an approved protocol, monitor participants closely, and let you leave. You are a volunteer with rights, not a test subject without a voice.

"Will joining go on my record? Will people find out?"

Your participation is private medical information, but privacy is not the same as invisibility. Ask exactly what goes into your medical record, what is sent to your regular doctor, and who can access study data. The rules can vary by study and by country.

"What if I am put on placebo and nobody helps me?"

Do not settle for a vague answer. Ask what support every group receives, how often you will be checked, and what triggers urgent help or removal from the study. If the answer does not make you feel safe, pause.

"What if I get worse after I start?"

Tell the team early. Getting worse is not a failure, and it should never be hidden to avoid disappointing the researchers. A responsible study has a safety plan, including a way to assess urgent problems and connect you with care. And if you are ever in immediate danger, contact local emergency services. Do not wait for a research appointment.

"Does joining a trial mean I have run out of options?"

No. A clinical trial is not automatically a last resort. Some people join after standard treatments have not worked. Others join because a study tests a treatment with fewer side effects, a more convenient schedule, or an approach aimed at their specific situation. The question is not whether a trial is "desperate." The question is whether this particular trial is a reasonable option for you.

Red flags that should make you pause

Be cautious if someone:

  • Promises a cure, or guarantees that you will receive the experimental treatment
  • Pressures you to sign immediately
  • Tells you to change or stop your current treatment without a supervised plan
  • Cannot clearly explain placebo, comparison groups, or randomization
  • Avoids questions about side effects, risks, or emergency support
  • Asks you to pay a large amount simply to access an experimental treatment
  • Will not give you a consent form or contact details for the study team

A real trial should be searchable in a recognized trial registry and should clearly identify the sponsor, study sites, eligibility criteria, and contact information. Registration alone does not prove that a trial is right for you, but missing basic information is a reason to slow down.

Take your time

A diagnosis can make decisions feel urgent. Families may also feel pressure to find the next answer quickly. But urgency should not take away your right to understand what you are agreeing to.

Ask questions. Read the consent form. Involve someone you trust. Talk to the doctor who already knows you. And remember that saying no to one study does not mean saying no to research forever.

If you are still searching, start with How to Search for Clinical Trials on TrialFinder, and keep our plain-language glossary open while you read listings.

The right trial is not simply one you can enter. It is one whose possible benefits, risks, time commitment, and safety plan you understand well enough to choose freely.

Related conditions

Epilepsy Clinical Trials: How Seizure Type and Drug Resistance Shape Eligibility Focal and generalized epilepsy, drug-resistant disease, and pediatric syndromes shape which epilepsy trials may fit. Plain-language guide plus recruiting studies.

Brain Tumor Clinical Trials: How Tumor Type and Biomarkers Shape Eligibility Glioblastoma, lower-grade glioma, and biomarkers such as IDH and MGMT change which brain tumor trials may fit. Plain-language guide plus recruiting studies.

Breast Cancer Clinical Trials: How Subtype and Biomarkers Shape Eligibility HR+/HER2−, HER2+, and TNBC, plus biomarkers such as BRCA and PIK3CA, shape which breast cancer trials may fit. Plain-language guide plus recruiting studies.

Pancreatic Cancer Clinical Trials: How Stage and Biomarkers Shape Eligibility PDAC, resectability, and biomarkers such as KRAS, BRCA, and MSI change which pancreatic cancer trials may fit. A plain-language guide, plus recruiting studies.

Lung Cancer Clinical Trials: How Type and Biomarkers Shape Eligibility NSCLC, SCLC, and biomarkers such as EGFR, ALK, and KRAS change which lung cancer trials may fit. A plain-language guide, plus recruiting studies.

Further reading

Start Here: How to Search for Clinical Trials on TrialFinder A step-by-step guide to finding clinical trials on TrialFinder. Learn how to search by condition, use filters, and understand your results.

What is a Clinical Trial? (It's More Than You Think) How clinical trials work, why they matter, and what patients should know before considering one.

Clinical Trials in Mental Health: What Patients and Families Should Know Mental health clinical trials can test medications, psychotherapy, TMS devices, digital therapeutics, and psychedelic-assisted treatment. Here is how they differ from cancer trials, and how to start looking.

How to Talk to Your Doctor About Clinical Trials What questions should you ask your doctor about clinical trials? A step-by-step guide for patients: when to bring it up, what to prepare, and what to do after.

Key Clinical Trial Terms Plain-language explanations of terms patients and families encounter during the clinical trial process.

Osimertinib for Uncommon EGFR Mutations: What the Evidence Shows Osimertinib (Tagrisso) for uncommon EGFR mutations such as G719X, S768I, L861Q, and exon 20 insertions: what the evidence covers, plus active clinical trials.

The Reminder Moderna and Merck's Personalized mRNA Cancer Vaccine Gives Us About Clinical Trials Moderna and Merck's personalized mRNA cancer vaccine just hit its Phase 3 endpoints in melanoma. Here's what it teaches us about the value of joining clinical trials.

Breakthrough in Pancreatic Cancer: Compassionate Use for KRAS Mutations Explained The new drug Daraxonrasib showed impressive survival results for eligible pancreatic cancer patients. It is currently available via compassionate use. Here is what you need to know.

Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway A rejection from a clinical trial doesn't have to be the end. Practical tips for patients and caregivers who hit a wall.

How to Talk About Clinical Trials with a Family Member A guide for caregivers on introducing clinical trials to a loved one who is hesitant, tired, or afraid.

Share this post
  •  

This article was written by a patient advocate based on personal experience, not by a medical professional. It is not medical advice. Consult your doctor before making any medical decisions.

Looking for a clinical trial?

Search trials